Literature DB >> 25359523

Validation of power Doppler versus contrast-enhanced magnetic resonance imaging quantification of joint inflammation in murine inflammatory arthritis.

Echoe M Bouta1, Peony D Banik, Ronald W Wood, Homaira Rahimi, Christopher T Ritchlin, Ralf G Thiele, Edward M Schwarz.   

Abstract

Contrast-enhancement magnetic resonance imaging (CE-MRI) of synovial volume is the radiographic gold standard to quantify joint inflammation; however, cost limits its use. Therefore, we examined if power Doppler-ultrasound (PD-US) outcomes of synovitis in tumor necrosis factor transgenic (TNF-Tg) mice correlate with CE-MRI. TNF-Tg mice underwent PD-US of their knees to measure the joint space volume (JSV) and power Doppler volume (PDV), and the results were correlated with synovial volume determined by CE-MRI. Immunohistochemistry for CD31 was performed to corroborate the PD signal. Synovial volume strongly correlated with both JSV and PDV (p < 0.01). CD31(+) blood vessels were observed in inflamed synovium proximal to the joint surface, which corresponded to areas of intense PD signals. JSV and PDV are valid measures of joint inflammation that correlate with synovial volume determined by CE-MRI and are associated with vascularity. Given the emergence of PD-US as a nonquantitative outcome of joint inflammation, we find JSV and PDV to be feasible and highly cost-effective for longitudinal studies in animal models. Furthermore, given the increasing use of PD-US in standard clinical practice, JSV and PDV could be translated to better quantify joint flare and response to therapy in patients with rheumatoid arthritis (RA).
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE ULTRASOUND; MAGNETIC RESONANCE IMAGING; MRI; RA; RHEUMATOID ARTHRITIS

Mesh:

Substances:

Year:  2015        PMID: 25359523      PMCID: PMC4376603          DOI: 10.1002/jbmr.2392

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

1.  Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis.

Authors:  Giusy Peluso; Alessandro Michelutti; Silvia Bosello; Elisa Gremese; Barbara Tolusso; Gianfranco Ferraccioli
Journal:  Ann Rheum Dis       Date:  2010-11-19       Impact factor: 19.103

2.  A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment.

Authors:  Hilde Berner Hammer; Margareth Sveinsson; Anne Katrine Kongtorp; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2010-05-14       Impact factor: 19.103

3.  Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis.

Authors:  Marcin Szkudlarek; Michel Court-Payen; Søren Jacobsen; Mette Klarlund; Henrik S Thomsen; Mikkel Østergaard
Journal:  Arthritis Rheum       Date:  2003-04

4.  Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis.

Authors:  M Ostergaard; M Hansen; M Stoltenberg; P Gideon; M Klarlund; K E Jensen; I Lorenzen
Journal:  Arthritis Rheum       Date:  1999-05

5.  Ultrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice.

Authors:  G Clavel; C Marchiol-Fournigault; G Renault; M-C Boissier; D Fradelizi; N Bessis
Journal:  Ann Rheum Dis       Date:  2008-01-24       Impact factor: 19.103

6.  Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging.

Authors:  K Gaffney; J Cookson; S Blades; A Coumbe; D Blake
Journal:  Ann Rheum Dis       Date:  1998-03       Impact factor: 19.103

7.  Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.

Authors:  Arne W Mould; Ian D Tonks; Marian M Cahill; Allison R Pettit; Ranjeny Thomas; Nicholas K Hayward; Graham F Kay
Journal:  Arthritis Rheum       Date:  2003-09

8.  Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography.

Authors:  Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2007-12

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis.

Authors:  Echoe M Bouta; Yawen Ju; Homaira Rahimi; Karen L de Mesy-Bentley; Ronald W Wood; Lianping Xing; Edward M Schwarz
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  8 in total

Review 1.  Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.

Authors:  Echoe M Bouta; Richard D Bell; Homaira Rahimi; Lianping Xing; Ronald W Wood; Clifton O Bingham; Christopher T Ritchlin; Edward M Schwarz
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

2.  Brief Report: Treatment of Tumor Necrosis Factor-Transgenic Mice With Anti-Tumor Necrosis Factor Restores Lymphatic Contractions, Repairs Lymphatic Vessels, and May Increase Monocyte/Macrophage Egress.

Authors:  Echoe M Bouta; Igor Kuzin; Karen de Mesy Bentley; Ronald W Wood; Homaira Rahimi; Rui-Cheng Ji; Christopher T Ritchlin; Andrea Bottaro; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheumatol       Date:  2017-04-04       Impact factor: 10.995

3.  Attenuated Joint Tissue Damage Associated With Improved Synovial Lymphatic Function Following Treatment With Bortezomib in a Mouse Model of Experimental Posttraumatic Osteoarthritis.

Authors:  Wensheng Wang; Xi Lin; Hao Xu; Wen Sun; Echoe M Bouta; Michael J Zuscik; Di Chen; Edward M Schwarz; Lianping Xing
Journal:  Arthritis Rheumatol       Date:  2019-01-05       Impact factor: 10.995

Review 4.  Lymphatic imaging to assess rheumatoid flare: mechanistic insights and biomarker potential.

Authors:  Homaira Rahimi; Richard Bell; Echoe M Bouta; Ronald W Wood; Lianping Xing; Christopher T Ritchlin; Edward M Schwarz
Journal:  Arthritis Res Ther       Date:  2016-09-01       Impact factor: 5.156

5.  Utilization of longitudinal ultrasound to quantify joint soft-tissue changes in a mouse model of posttraumatic osteoarthritis.

Authors:  Hao Xu; Echoe M Bouta; Ronald W Wood; Edward M Schwarz; Yongjun Wang; Lianping Xing
Journal:  Bone Res       Date:  2017-06-13       Impact factor: 13.567

6.  Multimodal [18 F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic Mice.

Authors:  Silvia Hayer; Markus Zeilinger; Volker Weiss; Monika Dumanic; Markus Seibt; Birgit Niederreiter; Tetyana Shvets; Florian Pichler; Wolfgang Wadsak; Bruno K Podesser; Thomas H Helbich; Marcus Hacker; Josef S Smolen; Kurt Redlich; Markus Mitterhauser
Journal:  J Bone Miner Res       Date:  2019-07-30       Impact factor: 6.741

7.  Ex vivo Demonstration of Functional Deficiencies in Popliteal Lymphatic Vessels From TNF-Transgenic Mice With Inflammatory Arthritis.

Authors:  Joshua P Scallan; Echoe M Bouta; Homaira Rahimi; H Mark Kenney; Christopher T Ritchlin; Michael J Davis; Edward M Schwarz
Journal:  Front Physiol       Date:  2021-09-27       Impact factor: 4.566

8.  Persistent popliteal lymphatic muscle cell coverage defects despite amelioration of arthritis and recovery of popliteal lymphatic vessel function in TNF-Tg mice following anti-TNF therapy.

Authors:  H Mark Kenney; Yue Peng; Richard D Bell; Ronald W Wood; Lianping Xing; Christopher T Ritchlin; Edward M Schwarz
Journal:  Sci Rep       Date:  2022-07-26       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.